NO883594L - Fremgangsmaate for fremstilling av preparater av dobbeltraadet rna. - Google Patents

Fremgangsmaate for fremstilling av preparater av dobbeltraadet rna.

Info

Publication number
NO883594L
NO883594L NO88883594A NO883594A NO883594L NO 883594 L NO883594 L NO 883594L NO 88883594 A NO88883594 A NO 88883594A NO 883594 A NO883594 A NO 883594A NO 883594 L NO883594 L NO 883594L
Authority
NO
Norway
Prior art keywords
various
procedure
preparation
rna preparations
double wired
Prior art date
Application number
NO88883594A
Other languages
English (en)
Norwegian (no)
Other versions
NO883594D0 (no
Inventor
William A Carter
Original Assignee
Hem Res Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hem Res Inc filed Critical Hem Res Inc
Publication of NO883594D0 publication Critical patent/NO883594D0/no
Publication of NO883594L publication Critical patent/NO883594L/no

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A61P31/20—Antivirals for DNA viruses
    • A61P31/22—Antivirals for DNA viruses for herpes viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H21/00—Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Virology (AREA)
  • Molecular Biology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Oncology (AREA)
  • Biochemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Biotechnology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Genetics & Genomics (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Saccharide Compounds (AREA)
  • Superconductors And Manufacturing Methods Therefor (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Breeding Of Plants And Reproduction By Means Of Culturing (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
NO88883594A 1987-08-12 1988-08-12 Fremgangsmaate for fremstilling av preparater av dobbeltraadet rna. NO883594L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8422787A 1987-08-12 1987-08-12

Publications (2)

Publication Number Publication Date
NO883594D0 NO883594D0 (no) 1988-08-12
NO883594L true NO883594L (no) 1989-02-13

Family

ID=22183617

Family Applications (1)

Application Number Title Priority Date Filing Date
NO88883594A NO883594L (no) 1987-08-12 1988-08-12 Fremgangsmaate for fremstilling av preparater av dobbeltraadet rna.

Country Status (19)

Country Link
EP (1) EP0308066B1 (fr)
JP (1) JPH01131119A (fr)
KR (1) KR0131879B1 (fr)
CN (1) CN1050995C (fr)
AT (1) ATE132041T1 (fr)
AU (3) AU2053588A (fr)
CA (1) CA1327002C (fr)
DE (1) DE3854829T2 (fr)
DK (1) DK449888A (fr)
FI (1) FI883763A7 (fr)
HU (1) HUT47854A (fr)
IE (1) IE72103B1 (fr)
IL (1) IL87413A0 (fr)
NO (1) NO883594L (fr)
NZ (1) NZ225799A (fr)
OA (1) OA08901A (fr)
PT (1) PT88266B (fr)
RU (1) RU1834663C (fr)
ZA (1) ZA885967B (fr)

Families Citing this family (22)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5593973A (en) * 1987-09-04 1997-01-14 Hemispherx Biopharma Inc. Treatment of viral hepatitis with mismatched dsRNA
EP0306347B1 (fr) * 1987-09-04 1995-05-10 Hem Pharmaceuticals Corp. Diagnostic des déficiences en RNA double-brin
US4963532A (en) * 1987-11-25 1990-10-16 Hem Research, Inc. dsRNA-based prevention of viral escape
EP0378621A4 (en) * 1988-05-23 1991-08-28 Steffen Gay Diagnostics and therapy for rheumatoid arthritis
EP0473576A4 (en) * 1989-05-19 1993-03-10 Hem Research, Inc. Short therapeutic dsrna of defined structure
ZA908037B (en) * 1989-10-11 1991-09-25 Hem Res Inc Protection from shock subsequent to injury by double-standed rnas
WO1991005560A1 (fr) * 1989-10-11 1991-05-02 Hem Research, Inc. Protection contre un choc posterieur a une blessure a l'aide d'arn bicatenaires
HUT65370A (en) * 1989-10-16 1994-05-02 Hem Res Inc Diagnosis and treatment of neuro-cognitive disorders associated with systemic immunological malfunction
CA2120027A1 (fr) * 1991-09-26 1993-04-01 William A. Carter Methode de neutralisation des effets du il-1 au moyen d'arm bicatenairse
US6506559B1 (en) 1997-12-23 2003-01-14 Carnegie Institute Of Washington Genetic inhibition by double-stranded RNA
WO1999049029A1 (fr) 1998-03-20 1999-09-30 Benitec Australia Ltd Controle d'expression genique
AUPP249298A0 (en) 1998-03-20 1998-04-23 Ag-Gene Australia Limited Synthetic genes and genetic constructs comprising same I
EP1147204A1 (fr) 1999-01-28 2001-10-24 Medical College Of Georgia Research Institute, Inc. Composition et methode destinees a l'attenuation in vivo et in vitro de l'expression genique utilisant de l'arn double brin
US6423885B1 (en) 1999-08-13 2002-07-23 Commonwealth Scientific And Industrial Research Organization (Csiro) Methods for obtaining modified phenotypes in plant cells
US7638496B2 (en) 2000-02-15 2009-12-29 Valeant Pharmaceuticals North America Nucleoside analogs with carboxamidine modified monocyclic base
CA2369944A1 (fr) 2001-01-31 2002-07-31 Nucleonics Inc. Utilisation de l'inhibition genetique post-transcriptionnelle pour identifier les sequences d'acides nucleiques qui modulent la fonction d'une cellule
CA2482903A1 (fr) * 2002-04-18 2003-10-23 Lynkeus Biotech Gmbh Moyens et procedes pour l'inhibition specifique de genes dans les cellules et le tissu du systeme nerveux central et/ou de l'oeil
US7148342B2 (en) 2002-07-24 2006-12-12 The Trustees Of The University Of Pennyslvania Compositions and methods for sirna inhibition of angiogenesis
WO2004022075A1 (fr) * 2002-09-04 2004-03-18 Novartis Ag Traitement de troubles neurologiques par administration d'arn bicaténaire
EP2134172A4 (fr) * 2007-03-05 2011-06-01 Univ Utah State Agoniste restrictif du récepteur 3 de type toll (tlr3)
CA2745832A1 (fr) 2008-12-04 2010-06-10 Opko Ophthalmics, Llc Compositions et procedes pour l'inhibition selective d'isoformes pro-angiogeniques de vegf
CN109355334A (zh) * 2018-12-06 2019-02-19 江苏省农业科学院 一种制备聚肌胞的方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1326450C (fr) * 1985-08-26 1994-01-25 William A. Carter Modulation des manifestations associees au virus du sida au moyen d'arn a double brin
AU1820388A (en) * 1987-07-17 1989-01-19 Hem Research, Inc. Double stranded rna correction of aberrant metabolic pathways associated with uncontrolled tumor cell and virus growth cycles

Also Published As

Publication number Publication date
ATE132041T1 (de) 1996-01-15
CA1327002C (fr) 1994-02-15
FI883763L (fi) 1989-02-13
PT88266A (pt) 1989-06-30
EP0308066A2 (fr) 1989-03-22
EP0308066B1 (fr) 1995-12-27
DE3854829T2 (de) 1996-08-14
KR890003402A (ko) 1989-04-14
DK449888A (da) 1989-02-13
IL87413A0 (en) 1989-01-31
DE3854829D1 (de) 1996-02-08
DK449888D0 (da) 1988-08-11
EP0308066A3 (fr) 1991-01-16
FI883763A0 (fi) 1988-08-12
RU1834663C (ru) 1993-08-15
NO883594D0 (no) 1988-08-12
AU2053588A (en) 1989-04-20
PT88266B (pt) 1995-05-04
CN1032740A (zh) 1989-05-10
FI883763A7 (fi) 1989-02-13
JPH01131119A (ja) 1989-05-24
AU1001595A (en) 1995-02-23
ZA885967B (en) 1989-07-26
IE72103B1 (en) 1997-03-12
AU1736792A (en) 1992-07-30
CN1050995C (zh) 2000-04-05
HUT47854A (en) 1989-04-28
IE882399L (en) 1989-02-12
NZ225799A (en) 1991-04-26
KR0131879B1 (ko) 1998-04-17
OA08901A (en) 1989-10-31

Similar Documents

Publication Publication Date Title
NO883594D0 (no) Fremgangsmaate for fremstilling av preparater av dobbeltraadet rna.
EP0400958A3 (fr) Vaccins vivants
ATE116637T1 (de) Sulfonische stilbenderivate zur behandlung von viruserkrankungen.
CA2314170A1 (fr) Procede de traitement prophylactique de la mastite
GR3022801T3 (en) Phenylalkan(en)oic acids with leukotriene B4 antagonistic activity.
JPS5519239A (en) Interferon-producing attractant
AU5684286A (en) Use of an aqueous, stabilised chlorite matrix solution for infectious conditions
WHEELER et al. Influence of specific antibody on herpes simplex infections in tissue culture
ES8704962A1 (es) Un procedimiento para preparar 1b-d-ribofuranosil, 1-2-4-triazol-3-carboxamida.
DE3767308D1 (de) Verwendung von sulfonamidderivaten zur herstellung eines antivirusmittels.
Vignaux et al. Enhanced expression of histocompatibility antigens on interferon-treated mouse embryonic fibroblasts
NO920255D0 (no) Podofyllotoksinpreparat som inneholder triglyserider
PT87940A (pt) Processo para a preparacao de dna do virus papillom humano tipo 41 e de proteinas por ele codificadas
Wargo Interaction of stress and secondary organisms in decline of forest trees.
DE69110470D1 (de) Herstellung von erhöhten Biokontrollwirkstoffen.
JPS5636483A (en) 66imidazolyll33hydrazinoopyridazine* its manufacture and medicine containing it
ES8104402A1 (es) Procedimiento para la preparacion de medicamentos inmunobio-terapicos a partir de cepas microbiologicas.
JPS5639098A (en) Novel oligosaccharide and its preparation
WO1988008707A3 (fr) Derives de rubradirine pour le traitement de l'infection hiv
JPS5492680A (en) Novel microorganism
ES2194860T3 (es) Composiciones que contienen timosina alfa 1 destinadas al tratamiento de pacientes que sufren una enfermedad hepatica descompensada.
KR870009018A (ko) 단순 포진에 대한 왁진